Publications by authors named "Juleen Cavanaugh"

Claim this Profile
C
Choice of Statistical Tools for Outlier Removal Causes Substantial Changes in Analyte Reference Intervals in Healthy Populations.
Peter E Hickman, Gus Koerbin, Julia M Potter, Nicholas Glasgow, Juleen A Cavanaugh

Clin Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a thyroid disease-free population to define the reference interval for TSH and free T4 on the Abbott Architect analyser.
Peter E Hickman, Gus Koerbin, Aaron Simpson, Julia M Potter, David G Hughes, Juleen Cavanaugh

Clin Endocrinol (Oxf)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonising Reference Intervals for Three Calculated Parameters used in Clinical Chemistry.
David Hughes, Gus Koerbin, Julia M Potter, Nicholas Glasgow, Nic West, Juleen Cavanaugh

Clin Biochem Rev· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of inflammatory bowel disease: the state of play.
Juleen A Cavanaugh

J Gastroenterol Hepatol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deleterious GRM1 mutations in schizophrenia.
Mohammed Akli Ayoub, Dora Angelicheva, David Vile, David Chandler, Bharti Morar, Juleen A Cavanaugh

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population.
Gus Koerbin, Jill Tate, Julia M Potter, Juleen Cavanaugh, Nicholas Glasgow

Clin Chem Lab Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population.
Lisa A Simms, James D Doecke, Rebecca L Roberts, Elizabeth V Fowler, Zhen Zhen Zhao, Juleen A Cavanaugh

Am J Gastroenterol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters.
Stefan Bröer, Charles G Bailey, Sonja Kowalczuk, Cynthia Ng, Jessica M Vanslambrouck, Juleen A Cavanaugh

J Clin Invest· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further evidence for allelic heterogeneity in Hartnup disorder.
Dimitar N Azmanov, Sonja Kowalczuk, Helen Rodgers, Christiane Auray-Blais, Robert Giguère, Juleen A Cavanaugh

Hum Mutat· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of Glu155 causes a deficiency of glutathione transferase Omega 1-1 but does not alter sensitivity to arsenic trioxide and other cytotoxic drugs.
Erica Schmuck, Jean Cappello, Marjorie Coggan, Jenny Brew, Juleen A Cavanaugh

Int J Biochem Cell Biol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity.
Elizabeth V Fowler, James Doecke, Lisa A Simms, Zhen Zhen Zhao, Penelope M Webb, Juleen A Cavanaugh

Am J Gastroenterol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of the common Hartnup disease D173N allele in populations of European origin.
Dimitar N Azmanov, Helen Rodgers, Christiane Auray-Blais, Robert Giguère, Charles Bailey, Juleen A Cavanaugh

Ann Hum Genet· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
Jean-Pierre Hugot, Isabelle Zaccaria, Juleen Cavanaugh, Huiying Yang, Séverine Vermeire

Am J Gastroenterol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Alissa Walsh, Jeannette L Dixon, Grant A Ramm, David G Hewett, Douglas J Lincoln, Juleen A Cavanaugh

Clin Gastroenterol Hepatol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOD2: ethnic and geographic differences.
Juleen Cavanaugh

World J Gastroenterol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for hemochromatosis in asymptomatic subjects with or without a family history.
Lawrie W Powell, Jeannette L Dixon, Grant A Ramm, David M Purdie, Douglas J Lincoln, Juleen A Cavanaugh

Arch Intern Med· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular basis of neutral aminoacidurias.
Angelika Bröer, Juleen A Cavanaugh, John E J Rasko, Stefan Bröer

Pflugers Arch· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases.
Erica M Schmuck, Philip G Board, Astrid K Whitbread, Natasha Tetlow, Juleen A Cavanaugh

Pharmacogenet Genomics· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association of the CD14 promoter polymorphism--159C/T with Caucasian inflammatory bowel disease.
Kirsten E Peters, Nathan J O'Callaghan, Juleen A Cavanaugh

Scand J Gastroenterol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction.
Marie Pierik, Huiying Yang, Michael M Barmada, Juleen A Cavanaugh, Vito Annese

Inflamm Bowel Dis· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19.
Heng F Seow, Stefan Bröer, Angelika Bröer, Charles G Bailey, Simon J Potter, Juleen A Cavanaugh

Nat Genet· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder.
Angelika Bröer, Karin Klingel, Sonja Kowalczuk, John E J Rasko, Juleen Cavanaugh

J Biol Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IBD International Genetics Consortium: international cooperation making sense of complex disease.
Juleen A Cavanaugh

Inflamm Bowel Dis· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic testing for HFE hemochromatosis in Australia: the value of testing relatives of simple heterozygotes.
Juleen A Cavanaugh, Susan R Wilson, Mark L Bassett

J Gastroenterol Hepatol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis